Resources

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Uganda by PATH, the Uganda National Expanded Program on Immunization of the Ministry of Health, and the Child Health and Development Centre, through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to almost 10,000 girls in select parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. This report interprets the results and summarizes helpful lessons for policymakers and program managers, especially those in sub-Saharan Africa, looking to shape their own HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Since 2009, PATH has been working with government family planning officials to engage stakeholders and apply evidence to develop a total market plan for family planning in light of funding shortfalls. This case study in Vietnam is intended to highlight lessons learned and recommendations for those considering similar initiatives in other settings. It is a sister document to the Nicaragua case study, Developing Total Market Strategies for Family Planning in Nicaragua.

This white paper highlights the value of a comprehensive approach to procurement capacity development in developing countries.

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website. It offers practical information to countries that plan to pilot, expand, or scale up human papillomavirus (HPV) vaccination programs. The main focus is on issues specific to HPV vaccination, such as working with a young adolescent target population in school settings and developing community support for HPV vaccination programs.

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Peru by PATH, Instituto de Investigación Nutricional, and Ministerio de Salud de Peru, Estrategia Sanitaria Nacional de Inmunizaciones through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to all girls aged nine years or older in grade 5 in selected parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. The publication will be useful for policymakers and program managers around the world, and especially in Latin America, who are designing public-sector HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.